Globus Medical (GMED) Reports In-Line Q3 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Globus Medical Reports Third Quarter 2016 Results
November 8, 2016 4:15 PM ESTAUDUBON, Pa., Nov. 08, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the third quarter ended September 30, 2016.
Worldwide sales decreased 1.0% as reported to $135.7 million, or a decrease of 0.7% on a constant currency basisThird quarter net income was $26.2 million, or 19.3% of salesDiluted earnings per share (EPS) were $0.27Non-GAAP diluted EPS were $0.29Non-GAAP adjusted EBITDA (AEBITDA) remained at 37.0% of salesCompany issues new 2016 guidance for sales of $560 millionDavid Paul, Chairman and CEO said,... More
